Adient (ADNT)
(Delayed Data from NYSE)
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
Zacks News
General Motors (GM) Partners With Anduril for Defense Program
by Zacks Equity Research
General Motors' (GM) unit, GM Defense LLC, collaborates with Anduril to deliver autonomy solutions, battery electrification and other new propulsion technologies.
Gentex (GNTX) Signs Stock Purchase Agreement With Avalon
by Zacks Equity Research
Gentex (GNTX) to buy 50% of Avalon Park Groups' total ownership stake in VOXX International Corporation.
Is Adient (ADNT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Adient (ADNT) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Implied Volatility Surging for Adient (ADNT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
Adient (ADNT) Down 12.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What Makes Adient (ADNT) a New Buy Stock
by Zacks Equity Research
Adient (ADNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Adient (ADNT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Adient (ADNT) Q3 Earnings & Sales Beat, Guidance Lifted
by Zacks Equity Research
Adient (ADNT) envisions fiscal 2023 revenues and adjusted EBITDA of $15.4 billion and $920 million, up from the prior guidance of $15 billion and $850 million, respectively.
Adient (ADNT) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Adient (ADNT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 151.28% and 6.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Commercial Vehicle Group (CVGI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Commercial Vehicle Group (CVGI) delivered earnings and revenue surprises of 28% and 0.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Adient (ADNT) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Sell Stocks for June 13th
by Zacks Equity Research
ADNY, BHKLY and EQH have been added to the Zacks Rank #5 (Strong Sell) List on June 13, 2023.
Adient (ADNT) Up 0.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Adient (ADNT) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Adient's (ADNT) second-quarter 2023 earnings lag estimates owing to weaker-than-expected EBITDA from the Americas segment.
Here's What Key Metrics Tell Us About Adient (ADNT) Q2 Earnings
by Zacks Equity Research
The headline numbers for Adient (ADNT) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Adient (ADNT) Lags Q2 Earnings Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -21.95% and 5.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Adient (ADNT) This Earnings Season?
by Zacks Equity Research
Adient (ADNT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BorgWarner (BWA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BorgWarner (BWA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adient (ADNT) Q1 Earnings Miss on Poor EMEA Unit Results
by Zacks Equity Research
Adient's (ADNT) fiscal Q1 earnings lag estimates owing to weaker-than-expected revenues and EBITDA from the EMEA unit.
Adient (ADNT) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -15% and 0.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
A Peek Into Key Predictions Ahead of Cummins (CMI) Q4 Earnings
by Zacks Equity Research
The Zacks Consensus Estimate for Cummins' (CMI) Q4 earnings per share and revenues is pegged at $4.66 and $7.36 billion, respectively.